Healthcare and Pharmaceuticals industry

Geriatric Medicines Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Geriatric Medicines Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Geriatric Medicines Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Geriatric Medicines Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Eli Lilly and Company
  • AstraZeneca
  • Boehringer Ingelheim
  • Abbott Laboratories
  • Sanofi
  • Bristol-Myers Squibb
  • Merck
  • Novartis
  • Pfizer
  • GSK

By the Product Type, the market is primarily segmented into:

  • Analgesics
  • Antihypertensives
  • Statins
  • Antidiabetics
  • Proton Pump Inhibitor
  • Anticoagulant
  • Antipsychotics
  • Antidepressants

By Applications, the market is segmented into:

  • Cardiovascular diseases
  • Arthritis
  • Neurological Disorders
  • Cancer
  • Osteoporosis
  • Respiratory

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Geriatric Medicines Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Geriatric Medicines Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Geriatric Medicines Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Geriatric Medicines Market

The Geriatric Medicines Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Geriatric Medicines Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Geriatric Medicines Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Geriatric Medicines
1.1 Geriatric Medicines Market Overview
1.1.1 Geriatric Medicines Product Scope
1.1.2 Market Status and Outlook
1.2 Global Geriatric Medicines Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Geriatric Medicines Market by Type
1.3.1 Global Geriatric Medicines Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Geriatric Medicines Revenue Market Share by Type in 2018
1.3.3 Analgesics
1.3.4 Antihypertensives
1.3.5 Statins
1.3.6 Antidiabetics
1.3.7 Proton Pump Inhibitor
1.3.8 Anticoagulant
1.3.9 Antipsychotics
1.3.10 Antidepressants
1.4 Geriatric Medicines Market by End Users/Application
1.4.1 Cardiovascular diseases
1.4.2 Arthritis
1.4.3 Neurological Disorders
1.4.4 Cancer
1.4.5 Osteoporosis
1.4.6 Respiratory

2 Global Geriatric Medicines Competition Analysis by Players
2.1 Global Geriatric Medicines Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans

3 Company (Top Players) Profiles and Key Data
3.1 Eli Lilly and Company
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 AstraZeneca
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Abbott Laboratories
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Sanofi
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Bristol-Myers Squibb
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Merck
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Novartis
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Pfizer
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 GSK
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.10.5 Recent Developments

4 Global Geriatric Medicines Market Size by Type and Application (2014-2019)
4.1 Global Geriatric Medicines Market Size by Type (2014-2019)
4.2 Global Geriatric Medicines Market Size by Application (2014-2019)
4.3 Potential Application of Geriatric Medicines in Future
4.4 Top Consumer/End Users of Geriatric Medicines

5 North America Geriatric Medicines Development Status and Outlook
5.1 North America Geriatric Medicines Market Size (2014-2019)
5.2 North America Geriatric Medicines Market Size and Market Share by Players (2014-2019)
5.3 North America Geriatric Medicines Market Size by Application (2014-2019)

6 Europe Geriatric Medicines Development Status and Outlook
6.1 Europe Geriatric Medicines Market Size (2014-2019)
6.2 Europe Geriatric Medicines Market Size and Market Share by Players (2014-2019)
6.3 Europe Geriatric Medicines Market Size by Application (2014-2019)

7 China Geriatric Medicines Development Status and Outlook
7.1 China Geriatric Medicines Market Size (2014-2019)
7.2 China Geriatric Medicines Market Size and Market Share by Players (2014-2019)
7.3 China Geriatric Medicines Market Size by Application (2014-2019)

8 Rest of Asia Pacific Geriatric Medicines Development Status and Outlook
8.1 Rest of Asia Pacific Geriatric Medicines Market Size (2014-2019)
8.2 Rest of Asia Pacific Geriatric Medicines Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Geriatric Medicines Market Size by Application (2014-2019)

9 Central & South America Geriatric Medicines Development Status and Outlook
9.1 Central & South America Geriatric Medicines Market Size (2014-2019)
9.2 Central & South America Geriatric Medicines Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Geriatric Medicines Market Size by Application (2014-2019)

10 Middle East & Africa Geriatric Medicines Development Status and Outlook
10.1 Middle East & Africa Geriatric Medicines Market Size (2014-2019)
10.2 Middle East & Africa Geriatric Medicines Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Geriatric Medicines Market Size by Application (2014-2019)

11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Geriatric Medicines Market Size by Regions (2019-2025)
11.1.1 North America Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.2 Europe Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.3 China Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.2 Global Geriatric Medicines Market Size by Application (2019-2025)
11.3 The Market Drivers in Future

12 Geriatric Medicines Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List

List of Table
List of Tables and Figures

Figure Global Geriatric Medicines Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Geriatric Medicines Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Geriatric Medicines Market Share by Regions (2014-2019)
Figure North America Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Geriatric Medicines Market Share by Type in 2018 & 2025
Figure Analgesics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antihypertensives Market Size (Million USD) and Growth Rate (2014-2019)
Figure Statins Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antidiabetics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Proton Pump Inhibitor Market Size (Million USD) and Growth Rate (2014-2019)
Figure Anticoagulant Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antipsychotics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antidepressants Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Geriatric Medicines Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Geriatric Medicines Market Share by Application in 2018 & 2025
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Cardiovascular diseases (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Arthritis (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Neurological Disorders (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Cancer (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Osteoporosis (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Respiratory (2014-2019)
Table Global Geriatric Medicines Revenue (Million US$) by Players (2014-2019)
Table Global Geriatric Medicines Revenue Market Share by Players (2014-2019)
Eigure Geriatric Medicines Market Size Share by Players in 2018
Table Global Geriatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Geriatric Medicines Market Share in 2018
Figure Global Top 10 Players Geriatric Medicines Market Share in 2018
Table Geriatric Medicines Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Eli Lilly and Company (2014-2019)
Table Eli Lilly and Company Geriatric Medicines Recent Developments
Table AstraZeneca Basic Information List
Table AstraZeneca Description and Business Overview
Table AstraZeneca Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of AstraZeneca (2014-2019)
Table AstraZeneca Geriatric Medicines Recent Developments
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Boehringer Ingelheim (2014-2019)
Table Boehringer Ingelheim Geriatric Medicines Recent Developments
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Abbott Laboratories (2014-2019)
Table Abbott Laboratories Geriatric Medicines Recent Developments
Table Sanofi Basic Information List
Table Sanofi Description and Business Overview
Table Sanofi Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Sanofi (2014-2019)
Table Sanofi Geriatric Medicines Recent Developments
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Bristol-Myers Squibb (2014-2019)
Table Bristol-Myers Squibb Geriatric Medicines Recent Developments
Table Merck Basic Information List
Table Merck Description and Business Overview
Table Merck Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Merck (2014-2019)
Table Merck Geriatric Medicines Recent Developments
Table Novartis Basic Information List
Table Novartis Description and Business Overview
Table Novartis Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Novartis (2014-2019)
Table Novartis Geriatric Medicines Recent Developments
Table Pfizer Basic Information List
Table Pfizer Description and Business Overview
Table Pfizer Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Pfizer (2014-2019)
Table Pfizer Geriatric Medicines Recent Developments
Table GSK Basic Information List
Table GSK Description and Business Overview
Table GSK Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of GSK (2014-2019)
Table GSK Geriatric Medicines Recent Developments
Table Global Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Figure Global Geriatric Medicines Revenue Market Share by Type in 2018
Table Global Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Global Geriatric Medicines Revenue Market by Application in 2018
Table Top Consumer/End Users of Geriatric Medicines
Figure North America Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure North America Geriatric Medicines Market Size Share by Players in 2018
Table North America Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure North America Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure North America Geriatric Medicines Market Size Share by Application in 2018
Figure Europe Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Europe Geriatric Medicines Market Size Share by Players in 2018
Table Europe Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Europe Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Europe Geriatric Medicines Market Size Share by Application in 2018
Figure China Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table China Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure China Geriatric Medicines Market Size Share by Players in 2018
Table China Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure China Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure China Geriatric Medicines Market Size Share by Application in 2018
Figure Rest of Asia Pacific Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Geriatric Medicines Market Size Share by Players in 2018
Table Rest of Asia Pacific Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Geriatric Medicines Market Size Share by Application in 2018
Figure Central & South America Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Geriatric Medicines Market Size Share by Players in 2018
Table Central & South America Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Central & South America Geriatric Medicines Market Size Share by Application in 2018
Figure Middle East & Africa Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Geriatric Medicines Market Size Share by Players in 2018
Table Middle East & Africa Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Geriatric Medicines Market Size Share by Application in 2018
Figure Global Geriatric Medicines Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Geriatric Medicines Market Size by Regions (2019-2025) (Million US$)
Figure Global Geriatric Medicines Market Size Share by Regions (2019-2025)
Figure Global Geriatric Medicines Market Size Share by Regions in 2025
Figure North America Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Geriatric Medicines Market Size by Application (2019-2025) (Million USD)
Figure Global Geriatric Medicines Market Size by Application (2019-2025)
Figure Global Geriatric Medicines Market Size by Application in 2025
Table Global Geriatric Medicines Market Size by Type (2019-2025) (Million US$)
Figure Global Geriatric Medicines Market Size by Type (2019-2025)
Figure Global Geriatric Medicines Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 



Contact Us

U.S.A :  +1-415-871-0703

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Testimonials

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.